methamphetamine and Cardiomyopathies

methamphetamine has been researched along with Cardiomyopathies in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.86)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (8.57)	29.6817
2010's	15 (42.86)	24.3611
2020's	16 (45.71)	2.80

Authors

Authors	Studies
Ahmad, S; Ahsan, MJ; Ahsan, MZ; Kapoor, V; Lateef, N; Latif, A; Lundgren, S; Mirza, M	1
Kaye, DM; Sanders, P; Scherer, DJ; Stokes, MB; Thoi, F	1
La Gerche, A; MacIsaac, A; Osekowski, M; Paratz, ED; Prior, D; Trytell, A	1
Bonomo, Y; Daugherty, S; Norman, A	1
Abdullah, CS; Aishwarya, R; Bhuiyan, MAN; Bhuiyan, MS; Goeders, NE; Hall, N; Hartman, B; Kevil, CG; King, J; Kolluru, GK; Murnane, KS; Nitu, S; Orr, AW; Remex, NS; Traylor, J	1
Kaye, DM; Sanders, P; Scherer, DJ; Stokes, MB; Teo, KS; Thoi, F; Win, KTH	1
Davis, JD	1
Bonomo, Y; Osekowski, M; Paratz, E; Somma, V	1
Chen, C; Du, Q; Lu, J; Wang, H; Zhang, C; Zhang, J; Zhang, M; Zhao, X	1
Bailey, SR; Bhuiyan, MAN; Bhuiyan, MS; Conrad, SA; Faisal, ASM; Goeders, NE; Kevil, CG; Orr, AW; Vanchiere, JA; Venkataraj, M	1
Arnold, CL; Bhuiyan, MS; Dominic, P; Goeders, NE; Kevil, CG; Kolluru, GK; Orr, AW; Traylor, JG; Woolard, MD	1
Gabriel, R; Kueh, SA; Looi, JL; Lund, M; Sutton, T; Wang, TKM	1
Crawford, MH; Deluna, A; Seng, S; Yu, EC; Zhao, SX	1
Ashby, D; Herring, K; Mims, L; Niblock, F	1
Elkayam, U; Moady, G; Ng, TMH; Oh, EE; Reddy, PKV	1
Abdullah, CS; Aishwarya, R; Alam, S; Arnold, CL; Bhuiyan, MAN; Bhuiyan, MS; Chandran, S; Dominic, P; Goeders, NE; Hartman, B; Kevil, CG; King, J; Kolluru, GK; Miriyala, S; Morshed, M; Nitu, S; Orr, AW; Panchatcharam, M; Remex, NS; Stokes, K; Traylor, J; Woolard, MD; Yu, X	1
Chau, E; Elkayam, U; Ng, TM; Patel, SV; Reddy, PK; Yang, K	1
Elkayam, U; Reddy, P	1
Bosch, X; Flores-Umanzor, EJ; Ortega-Paz, L; Perea, RJ; Pujol-López, M	1
Klingel, K; Linke, A; Lurz, P; Mangner, N; Schürer, S	1
Katus, HA; Raake, PW; Schwab, DM	1
Phillips, SD; Pierce, SL; Williams, M; Zantow, EW	1
Kandolf, R; Klingel, K; Sandri, M; Schuler, G; Wilde, J	1
Hong, RA; Parikh, NI; Seto, TB; Shohet, RV; Won, S	1
Cunningham, NJ; MacIsaac, AI; Paratz, ED	1
Fernando, H; Stokes, MB; Taylor, AJ	1
Bloom, JE; Ihle, JF; Kaye, DM; Voskoboinik, A	1
Madias, JE	1
Adigopula, S; Borger, R; Dong, F; Kulczycki, M; Lee, C; Neeki, MM; Toy, J	1
Afshari, R; Dabbagh Kakhki, VR; Dadpour, B; Dorri-Giv, M; Ghahremani, S; Mohajeri, SA	1
Chung, JH; Hernandez Conte, A; LaBounty, T; Lubin, L; Padilla, C; Ramzy, D; Zeng, Y	1
Buonocore, M; Caputo, G; Lopez, JE; Schaefer, S; Yeo, K	1
Alimineti, K; Efird, JT; Ito, H; Kimata, C; Schatz, IJ; Seto, TB; Tay, K; Wijetunga, M; Yeo, KK	1
Ambrose, J; Barua, R; Srikanth, S	1
Ishiyama, I; Kaiho, M	1

Reviews

9 review(s) available for methamphetamine and Cardiomyopathies

Article	Year
Is Methamphetamine-Linked Cardiomyopathy an Emerging Epidemic for New Generation? Current problems in cardiology, 2023, Volume: 48, Issue:1 Topics: Cardiomyopathies; Cardiovascular Diseases; Humans; Hypertension, Pulmonary; Methamphetamine	2023
Methamphetamine-Associated Cardiomyopathy: Addressing the Clinical Challenges. Heart, lung & circulation, 2022, Volume: 31, Issue:5 Topics: Amphetamine-Related Disorders; Cardiomyopathies; Heart Failure; Humans; Methamphetamine	2022
A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022, Volume: 22, Issue:4 Topics: Cardiomyopathies; Central Nervous System Stimulants; Heart Failure; Humans; Methamphetamine	2022
Methamphetamine-associated cardiomyopathy: an addiction medicine perspective. Internal medicine journal, 2023, Volume: 53, Issue:1 Topics: Addiction Medicine; Amphetamine-Related Disorders; Cardiomyopathies; Central Nervous System Stimulants; Humans; Methamphetamine	2023
Methamphetamine Use and Cardiovascular Disease. Arteriosclerosis, thrombosis, and vascular biology, 2019, Volume: 39, Issue:9 Topics: Arrhythmias, Cardiac; Atherosclerosis; Cardiomyopathies; Cardiovascular Diseases; Humans; Hypertension, Pulmonary; Methamphetamine; Vasoconstriction	2019
Clinical Characteristics and Management of Methamphetamine-Associated Cardiomyopathy: State-of-the-Art Review. Journal of the American Heart Association, 2020, 06-02, Volume: 9, Issue:11 Topics: Amphetamine-Related Disorders; Animals; Cardiomyopathies; Central Nervous System Stimulants; Heart; Humans; Methamphetamine; Predictive Value of Tests; Recovery of Function; Risk Factors; Treatment Outcome	2020
[Cardiomyopathy in a 22-year-old man with a long history of methamphetamine abuse]. Der Internist, 2019, Volume: 60, Issue:3 Topics: Cardiomyopathies; Cardiomyopathy, Dilated; Echocardiography; Heart Valve Prosthesis Implantation; Humans; Male; Methamphetamine; Mitral Valve; Mitral Valve Insufficiency; Substance-Related Disorders; Treatment Outcome; Young Adult	2019
Methamphetamine-associated cardiomyopathy. Clinical cardiology, 2013, Volume: 36, Issue:12 Topics: Amphetamine-Related Disorders; Animals; Cardiomyopathies; Central Nervous System Stimulants; Humans; Incidence; Methamphetamine; Prevalence; Prognosis; Risk Assessment; Risk Factors	2013
The Cardiac Complications of Methamphetamines. Heart, lung & circulation, 2016, Volume: 25, Issue:4 Topics: Acute Coronary Syndrome; Advisory Committees; Animals; Aortic Rupture; Australia; Cardiomyopathies; Humans; Hypertension; Hypertension, Pulmonary; Methamphetamine; Substance-Related Disorders	2016

Other Studies

26 other study(ies) available for methamphetamine and Cardiomyopathies

Article	Year
Comment on: "A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy". American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022, Volume: 22, Issue:4 Topics: Cardiomyopathies; Humans; Methamphetamine	2022
Mitochondrial dysfunction and autophagy activation are associated with cardiomyopathy developed by extended methamphetamine self-administration in rats. Redox biology, 2022, Volume: 58 Topics: Animals; Autophagy; Cardiomyopathies; Central Nervous System Stimulants; Humans; Methamphetamine; Mitochondria; Rats	2022
Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathy. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2022, 12-01, Volume: 24, Issue:1 Topics: Adult; Cardiomyopathies; Cohort Studies; Contrast Media; Cytidine Monophosphate; Female; Gadolinium; Heart Failure; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Predictive Value of Tests; Retrospective Studies; Ventricular Septum	2022
Too much heterogeneity: envisioning a new approach to methamphetamine associated heart failure. Heart (British Cardiac Society), 2023, 01-11, Volume: 109, Issue:3 Topics: Cardiomyopathies; Heart Failure; Humans; Methamphetamine	2023
Methamphetamine induces cardiomyopathy through GATA4/NF-κB/SASP axis-mediated cellular senescence. Toxicology and applied pharmacology, 2023, 05-01, Volume: 466 Topics: Animals; Cardiomyopathies; Cellular Senescence; GATA4 Transcription Factor; Methamphetamine; Mice; Myocytes, Cardiac; NF-kappa B; Stroke Volume; Ventricular Function, Left	2023
Disparities in Prevalence and Trend of Methamphetamine-Associated Cardiomyopathy in the United States. Journal of the American College of Cardiology, 2023, 05-09, Volume: 81, Issue:18 Topics: Cardiomyopathies; Cardiomyopathy, Dilated; Humans; Methamphetamine; Prevalence; United States	2023
Poor outcomes in methamphetamine-associated cardiomyopathy-a growing health issue in New Zealand. The New Zealand medical journal, 2019, 09-20, Volume: 132, Issue:1502 Topics: Adult; Cardiomyopathies; Cardiotoxicity; Central Nervous System Stimulants; Cohort Studies; Female; Heart Arrest; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Methamphetamine; New Zealand; Prognosis; Substance-Related Disorders	2019
Comparison of Clinical Characteristics and Outcomes of Patients With Reversible Versus Persistent Methamphetamine-Associated Cardiomyopathy. The American journal of cardiology, 2020, 01-01, Volume: 125, Issue:1 Topics: Amphetamine-Related Disorders; California; Cardiomyopathies; Cause of Death; Dopamine Agents; Echocardiography; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Methamphetamine; Middle Aged; Retrospective Studies; Stroke Volume; Survival Rate; Ventricular Function, Left	2020
Acute Heart Failure in a 39-Year-Old Man. American family physician, 2020, 01-15, Volume: 101, Issue:2 Topics: Adult; Cardiomyopathies; Central Nervous System Stimulants; Heart Failure; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Methamphetamine	2020
Methamphetamine induces cardiomyopathy by Sigmar1 inhibition-dependent impairment of mitochondrial dynamics and function. Communications biology, 2020, 11-17, Volume: 3, Issue:1 Topics: Animals; Cardiomyopathies; Cyclic AMP Response Element-Binding Protein; Drug Administration Schedule; Gene Expression Regulation; Heart; Humans; Methamphetamine; Mice; Mitochondria; Mitochondrial Proteins; Myocardium; Myocytes, Cardiac; Receptors, sigma; Sigma-1 Receptor	2020
Characteristics of Methamphetamine-associated Cardiomyopathy and the Impact of Methamphetamine Use on Cardiac Dysfunction. The American journal of cardiology, 2021, 09-01, Volume: 154 Topics: Administration, Intranasal; Adult; Amphetamine-Related Disorders; Cardiomyopathies; Cardiotoxicity; Case-Control Studies; Central Nervous System Stimulants; Echocardiography; Female; Humans; Male; Methamphetamine; Middle Aged; Smoking; Stroke Volume; Ventricular Dysfunction, Left	2021
The Hidden Cost of Meth: Appraising the Socioeconomic Burden of Methamphetamine-Associated Cardiomyopathy. Circulation. Cardiovascular quality and outcomes, 2021, Volume: 14, Issue:7 Topics: Cardiomyopathies; Humans; Methamphetamine; Socioeconomic Factors	2021
Cardiac Magnetic Resonance as an Alternative to Endomyocardial Biopsy to Predict Recoverability of Left Ventricular Function in Methamphetamine- Associated Cardiomyopathy. JACC. Heart failure, 2017, Volume: 5, Issue:11 Topics: Biopsy; Cardiomyopathies; Heart Failure; Humans; Magnetic Resonance Spectroscopy; Methamphetamine; Ventricular Function, Left	2017
Reply: Cardiac Magnetic Resonance as an Alternative to Endomyocardial Biopsy to Predict Recoverability of Left Ventricular Function in Methamphetamine-Associated Cardiomyopathy. JACC. Heart failure, 2017, Volume: 5, Issue:11 Topics: Biopsy; Cardiomyopathies; Heart Failure; Humans; Magnetic Resonance Spectroscopy; Methamphetamine; Ventricular Function, Left	2017
Methamphetamine-Associated Cardiomyopathy in Pregnancy: A Case Series. Mayo Clinic proceedings, 2019, Volume: 94, Issue:3 Topics: Adult; Amphetamine-Related Disorders; Cardiomyopathies; Female; Humans; Methamphetamine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Care; Prenatal Exposure Delayed Effects	2019
["Catecholamine refractory" cardiogenic shock? "Bridging-to-recovery" by implantation of a percutaneous cardiac assist device]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:12 Topics: Adult; Amphetamine-Related Disorders; Biopsy; Cardiomyopathies; Catecholamines; Cooperative Behavior; Drug Resistance; Echocardiography; Epinephrine; Extracorporeal Membrane Oxygenation; Heart-Assist Devices; Home Care Services; Humans; Interdisciplinary Communication; Male; Methamphetamine; Myocarditis; Myocardium; Patient Care Team; Percutaneous Coronary Intervention; Prosthesis Design; Shock, Cardiogenic	2013
Cardiogenic shock secondary to methamphetamine induced cardiomyopathy requiring veno-arterial extra-corporeal membrane oxygenation. International journal of cardiology, 2016, Mar-15, Volume: 207 Topics: Adult; Cardiomyopathies; Extracorporeal Membrane Oxygenation; Humans; Male; Methamphetamine; Shock, Cardiogenic	2016
Methamphetamine-associated cardiomyopathy: patterns and predictors of recovery. Internal medicine journal, 2016, Volume: 46, Issue:6 Topics: Adult; Cardiomyopathies; Echocardiography; Female; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Myocardium; Retrospective Studies; Stroke Volume; Takotsubo Cardiomyopathy; Victoria	2016
Methamphetamine-triggered Takotsubo syndrome and methamphetamine-associated cardiomyopathy: a continuum? Internal medicine journal, 2016, Volume: 46, Issue:6 Topics: Cardiomyopathies; Humans; Methamphetamine; Precipitating Factors; Takotsubo Cardiomyopathy	2016
Frequency of Methamphetamine Use as a Major Contributor Toward the Severity of Cardiomyopathy in Adults ≤50 Years. The American journal of cardiology, 2016, 08-15, Volume: 118, Issue:4 Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cardiomyopathies; Female; Heart Failure; Humans; Male; Methamphetamine; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Severity of Illness Index; Stroke Volume; United States; Ventricular Dysfunction, Left; Young Adult	2016
Myocardial perfusion and left ventricular function indices assessed by gated myocardial perfusion SPECT in methamphetamine abusers. Nuclear medicine communications, 2016, Volume: 37, Issue:12 Topics: Adult; Amphetamine-Related Disorders; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Cardiomyopathies; Humans; Male; Methamphetamine; Middle Aged; Myocardial Perfusion Imaging; Ventricular Function, Left	2016
Utilization of "Stand-By" Extracorporeal Membrane Oxygenation in a High-Risk Parturient With Methamphetamine-Associated Cardiomyopathy Undergoing Dilation and Evacuation: A Case Report. A & A case reports, 2017, Mar-01, Volume: 8, Issue:5 Topics: Abortion, Therapeutic; Adult; Cardiomyopathies; Central Nervous System Stimulants; Diabetes Mellitus, Type 2; Extracorporeal Membrane Oxygenation; Female; Humans; Hypertension; Methamphetamine; Obesity, Morbid; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy, Triplet; Ventricular Dysfunction, Left	2017
Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2009, Nov-11, Volume: 11 Topics: Adult; Cardiomyopathies; Central Nervous System Stimulants; Contrast Media; Electrocardiography; Female; Fibrosis; Gadolinium DTPA; Humans; Magnetic Resonance Imaging, Cine; Methamphetamine; Myocardium; Predictive Value of Tests; Recovery of Function; Severity of Illness Index; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left	2009
The association of methamphetamine use and cardiomyopathy in young patients. The American journal of medicine, 2007, Volume: 120, Issue:2 Topics: Adult; Cardiomyopathies; Case-Control Studies; Female; Humans; Male; Methamphetamine; Middle Aged; Odds Ratio; Risk Factors; Substance-Related Disorders	2007
Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy. Cardiology, 2008, Volume: 109, Issue:3 Topics: Adult; Cardiomyopathies; Diagnosis, Differential; Echocardiography; Electrocardiography; Female; Humans; Methamphetamine; Substance-Related Disorders; Ventricular Dysfunction, Left	2008
Morphological study of acute myocardial lesions experimentally induced by methamphetamine. Nihon hoigaku zasshi = The Japanese journal of legal medicine, 1989, Volume: 43, Issue:6 Topics: Acute Disease; Animals; Cardiomyopathies; Climate; Hot Temperature; Humidity; Injections, Intraperitoneal; Methamphetamine; Microscopy, Electron; Myocardium; Rats; Rats, Inbred Strains; Toxicology	1989